Cempra (CEMP:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
CXDC China XD Plastics Co Ltd 4.700000 49511541 3.2639 0.3926 5.65 -11.27
CEMP Cempra Inc 3.150000 52509281 None 1.0853 3.56 3.33
OPHT Ophthotech Corp 2.620000 35942879 None None 3.92 5.86
MLNK ModusLink Global Solutions Inc 1.570000 55554589 None 1.2654 2.02 0.96
GURE Gulf Resources Inc 1.770000 46796848 2.1585 0.2176 3.77 3.72
SRRA Sierra Oncology Inc 1.550000 52268443 None 0.7214 2.23 0.46
CXRX Concordia International Corp 1.320000 51143978 None None 5.90 -63.98
INFI Infinity Pharmaceuticals Inc 1.210000 50689512 None 1.0413 1.31 1.10
ECYT Endocyte Inc 1.420000 42575444 None 0.5214 1.53 0.84
WLB Westmoreland Coal Co 2.240000 18742143 None None 3.07 -54.31
APWC Asia Pacific Wire & Cable Corp Ltd 2.850000 13819669 13.5714 0.2897 3.49 1.44
EVK Ever-Glory International Group Inc 2.500000 14792836 4.8077 0.4435 2.56 0.00
PRPH ProPhase Labs Inc 2.280000 16166796 2.6824 0.7906 2.31 2.31
OREX Orexigen Therapeutics Inc 2.300000 15430966 None None 2.38 -8.74
GIGM GigaMedia Ltd 3.010000 11052235 None 0.5528 6.01 5.77
TNXP Tonix Pharmaceuticals Holding Corp 4.270100 7508661 None 0.9439 4.58 0.24
VLRX Valeritas Holdings Inc 3.250000 6842978 3.5532 1.1761 6.18 1.20
ABAC Aoxin Tianli Group Inc 2.160000 7983745 None 0.1998 7.25 6.99
CBIO Catalyst Biosciences Inc 3.530000 4310561 None 0.5014 7.51 6.18
TEAR TearLab Corp 1.510000 5742453 None None 1.78 -2.98
GLBR Global Brokerage Inc 1.250000 6143305 0.8636 None 77.62 50.74
KONE Kingtone Wirelessinfo Solution Holding Ltd 3.120100 1405000 15.6005 0.2390 4.00 10.61
MDGS Medigus Ltd 2.040000 1992571 None 1.1112 4.23 None
ROSG Rosetta Genomics Ltd 1.430000 2639375 None 0.8545 2.34 0.90
KBSF KBS Fashion Group Ltd 1.980000 1772016 None 0.0426 13.49 12.01

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.


Cempra has 45 employees and is headquartered in United States.
Cempra Inc is a biotechnology company which develops differentiated antibiotics for acute care and community settings. Its goal is to develop treatments for bacterial infectious diseases, mainly respiratory tract infections and staphylococcal infections.

OPHT:NAS Ophthotech

Ophthotech has 156 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.